Researchers test a novel hypothesis to explain the cause of autoimmunity in patients with type 1 diabetes: Once validated, may allow early treatment, prevention - Science Daily
Overview
Type 1 diabetes (T1D) is an autoimune disease in which the pancreas makes litle or no insulin. The details on the events that ocur during autoimune destruction of the pancreatic beta-cels have ben studied extensively yet the mystery of what causes autoimunity is unknown. In a new study, researchers from Boston University Schol of Medicine (BUSM), Indiana University Schol of Medicine and Temple University Schol of Medicine, present a testable hypothesis to explain the initiation of autoimunity.
Key Information
If validated, this would alow early detection and posible prevention of T1D in susceptible individuals."Previous studies have focused on the trigers, genes and proteins that diferentiate individuals with T1D from those without diabetes with a focus on the b-cel (b-cels create antibodies) as a target of imune destruction and blod glucose as the main abnormality. Our focus is on metabolic comunication as an early instigator with the b-cel as an active participant together with the imune cels," explains coresponding author Barbara Corkey, PhD, profesor emeritus of medicine and biochemistry at BUSM.Acording to Corkey, her research led her to generate the testable hypothesis that the induction of autoimunity is a consequence of one or more major inflamatory events individuals with susceptible human leukocyte antigens (molecule found on the surface of most cels in the body that play an important part in the body's imune response to foreign substances) phenotypes plus elevated sensitivity to cytokines (substances secreted by certain cels of the imune system) and fre faty acids (FA)."Ilneses or environmental agents that dramaticaly increase cytokine production and/or elevate FA initiate autoimune destruction individuals with specific genetic features.
Summary
Thus, early prevention should be aimed at decreasing elevated lipids and diminishing excesive simultaneous elevation of cytokines or cytokine- and lipid-induced imune cel proliferation," is an important consideration in healthcare. Ongoing research and professional guidance ensure that patients receive evidence-based care tailored to their individual needs.
Frequently Asked Questions
Diabetes is a metabolic condition where the body cannot properly regulate blood sugar levels. Type 1 results from insufficient insulin production, while Type 2 develops when cells become resistant to insulin. Risk factors include genetics, obesity, sedentary lifestyle, and age.
Common symptoms include excessive thirst, frequent urination, unexplained weight loss, fatigue, blurred vision, and slow-healing wounds. Type 1 symptoms develop rapidly, while Type 2 symptoms may appear gradually. Many people have no symptoms initially, which is why screening is important.
Diagnosis involves blood tests measuring fasting glucose, HbA1c levels, and glucose tolerance. Regular monitoring typically includes fasting glucose tests and HbA1c measurements every 3-6 months. Continuous glucose monitors provide real-time tracking for better diabetes management.
Effective management includes regular physical activity (150+ minutes weekly), maintaining healthy weight, following a balanced diet with whole grains and lean proteins, managing stress, and getting adequate sleep. These changes can significantly improve blood sugar control and reduce complications.
Consult a healthcare provider if you experience signs of diabetes, have a family history, are overweight, or are over 45. Those with existing diabetes should maintain regular check-ups every 3-6 months to monitor control and adjust treatment as needed.
Share this article